standard review) Late 2027 to mid-2028: Market launch if approved TRIUMPH trial program: All four core registrational trials complete TRIUMPH-4 (28.7%), TRIUMPH-1 (28.3%), TRIUMPH-2 (20.8%, obesity + diabetes), TRIUMPH-3 (22.6%, obesity + cardiovascular disease)
To learn more or schedule a consultation, call (424) 382-1074 today.
Back Mojsov, S, Kopczynski, MG, Habener, JF (15 May 1990 )'Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas', Journal of Biological Chemistry , 265/14, 8001-8
Participation in clinical trials may be possible for eligible individuals
When Are GLP-1 RAs Right for People Who Have Already Had Bariatric Surgery